| Vishal Garimella, MBBS | |
|
4201 Medical Center Drive, Mchenry, IL 60050 | |
| (815) 344-5000 | |
| Not Available |
| Full Name | Vishal Garimella |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 4201 Medical Center Drive, Mchenry, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023712304 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 125081938 (Illinois) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Vishal Garimella, MBBS 4201 Medical Center Drive, Mchenry, IL 60050 Ph: (815) 344-5000 | Vishal Garimella, MBBS 4201 Medical Center Drive, Mchenry, IL 60050 Ph: (815) 344-5000 |
News Archive
A pioneering clinical trial investigating medicinal cannabis as a potential treatment for people living with severe Tourette syndrome will be conducted by Wesley Medical Research, in Brisbane in Australia, with cannabis supply facilitated by Lambert Initiative for Cannabinoid Therapeutics at University of Sydney.
Johns Hopkins researchers report they have figured out how the aptly named protein Botch blocks the signaling protein called Notch, which helps regulate development. In a report on the discovery, to appear online April 24 in the journal Cell Reports, the scientists say they expect the work to lead to a better understanding of how a single protein, Notch, directs actions needed for the healthy development of organs as diverse as brains and kidneys.
Alkermes, Inc. today announced that it has submitted a supplemental New Drug Application (sNDA) for VIVITROL® (naltrexone for extended-release injectable suspension) to the U.S. Food and Drug Administration (FDA) for approval as a treatment for opioid dependence. The company requested a priority review for its sNDA and if granted by the FDA, it would mean a six month review timeline.
Electromagnetic pulses significantly decrease pain and inflammation associated with osteoarthritis of the knee, according to Henry Ford Hospital researchers.
The advanced phase of acute kidney injury can be fatal in even one in two patients. Fortunately, now it will be possible to detect the disease in its initial stages, when treatment is still relatively simple and the prognosis good.
› Verified 7 days ago
Pakhadi H Buddhadev, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4201 W Medical Center Dr Dept Of, Mchenry, IL 60050 Phone: 815-759-4323 Fax: 815-759-4948 | |
Dr. Prashant Sura, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4309 W Medical Center Dr Ste A102, Mchenry, IL 60050 Phone: 815-338-6600 | |
Thiago Gagliano Juca Domingues De Oliveira, MD, PHD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 4201 W Medical Center Dr, Mchenry, IL 60050 Phone: 815-338-6600 | |
Parmod Narang, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4318 W Crystal Lake Rd, Ste J Drs Narang And Associates Ltd, Mchenry, IL 60050 Phone: 815-344-1500 Fax: 815-344-3685 | |
Dr. Shaji Mariyam Baig, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4309 W Medical Center Dr Ste A102, Mchenry, IL 60050 Phone: 815-759-4323 | |
Ms. Sonika Bindu Prasad, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 4201 Medical Center Drive, Mchenry, IL 60050 Phone: 315-338-6600 |